GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » Repurchase of Stock

PharmaLundensis AB (XSAT:PHAL) Repurchase of Stock : kr-3.26 Mil (TTM As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB Repurchase of Stock?

PharmaLundensis AB's Repurchase of Stock for the three months ended in Dec. 2024 was kr0.00 Mil.

PharmaLundensis AB's Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2024 was kr-3.26 Mil.

PharmaLundensis AB Repurchase of Stock Historical Data

The historical data trend for PharmaLundensis AB's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaLundensis AB Repurchase of Stock Chart

PharmaLundensis AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Repurchase of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PharmaLundensis AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.23 - -3.03 -

PharmaLundensis AB Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaLundensis AB Repurchase of Stock Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Repurchase of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » Repurchase of Stock
Comparable Companies
XSAT:RESP XSAT:DBP B OSTO:CMOTEC B OSTO:QUIA OSTO:NANECH OSTO:STABL XSAT:APTA OSTO:MODTX OSTO:FLUI OSTO:SPRINT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63
Website
http://www.pharmalundensis.se
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.

PharmaLundensis AB Headlines

No Headlines